As of Feb 11
| +0.60 / +1.73%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 45.00, with a high estimate of 45.00 and a low estimate of 40.00. The median estimate represents a +27.84% increase from the last price of 35.20.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.